Mereo BioPharma Group plc (MREO): Total Liabilities
$5.00M
As of 2025-12-31
$6.06M
As of 2026-06-30
-42.3%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.00M | -67.6% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $15.42M | -3.4% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $15.96M | -38.6% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $26.01M | n/a | 2024-03-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $69.14M | +0.8% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $2.40M | -83.8% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $5.08M | -14.4% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
Compare MREO, LIPO, QUCY, SLN side by side · Screen every company in Pharmaceutical Preparations ↗